Report Detail

Medical Devices & Consumables Global Cancer Biomarker Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4598909
  • |
  • 02 July, 2024
  • |
  • Global
  • |
  • 137 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Cancer Biomarker market size was valued at USD 20140 million in 2023 and is forecast to a readjusted size of USD 41530 million by 2030 with a CAGR of 10.9% during review period.
Cancer biomarkers are substances or processes that are indicative of the presence of cancers in the human body. Biomarkers may be produced by the cancer tissue itself or by other cells in the body in response to cancer. They can be found in the blood, stool, urine, tumor tissue, or other tissues or bodily fluids.
The Global Info Research report includes an overview of the development of the Cancer Biomarker industry chain, the market status of Diagnostics (Protein Biomarker, Genetic Biomarker), Research (Protein Biomarker, Genetic Biomarker), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cancer Biomarker.
Regionally, the report analyzes the Cancer Biomarker markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cancer Biomarker market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cancer Biomarker market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cancer Biomarker industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Protein Biomarker, Genetic Biomarker).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cancer Biomarker market.
Regional Analysis: The report involves examining the Cancer Biomarker market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cancer Biomarker market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cancer Biomarker:
Company Analysis: Report covers individual Cancer Biomarker manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cancer Biomarker This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Diagnostics, Research).
Technology Analysis: Report covers specific technologies relevant to Cancer Biomarker. It assesses the current state, advancements, and potential future developments in Cancer Biomarker areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cancer Biomarker market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cancer Biomarker market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Protein Biomarker
Genetic Biomarker
Market segment by Application
Diagnostics
Research
Others
Major players covered
Thermo Fisher Scientific
Bio-Rad Laboratories
Roche Diagnostics
Qiagen
Illumina
GE Healthcare
Agilent Technologies
Biomérieux SA
Merck & Co.
Abbott Laboratories
Becton, Dickinson and Company
Danaher Corporation
Myriad Genetics
Sysmex Corporation
Hologic
Quest Diagnostics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Biomarker product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cancer Biomarker, with price, sales, revenue and global market share of Cancer Biomarker from 2019 to 2024.
Chapter 3, the Cancer Biomarker competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Biomarker breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Cancer Biomarker market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cancer Biomarker.
Chapter 14 and 15, to describe Cancer Biomarker sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Cancer Biomarker
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Cancer Biomarker Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Protein Biomarker
    • 1.3.3 Genetic Biomarker
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Cancer Biomarker Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Diagnostics
    • 1.4.3 Research
    • 1.4.4 Others
  • 1.5 Global Cancer Biomarker Market Size & Forecast
    • 1.5.1 Global Cancer Biomarker Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Cancer Biomarker Sales Quantity (2019-2030)
    • 1.5.3 Global Cancer Biomarker Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Thermo Fisher Scientific
    • 2.1.1 Thermo Fisher Scientific Details
    • 2.1.2 Thermo Fisher Scientific Major Business
    • 2.1.3 Thermo Fisher Scientific Cancer Biomarker Product and Services
    • 2.1.4 Thermo Fisher Scientific Cancer Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.2 Bio-Rad Laboratories
    • 2.2.1 Bio-Rad Laboratories Details
    • 2.2.2 Bio-Rad Laboratories Major Business
    • 2.2.3 Bio-Rad Laboratories Cancer Biomarker Product and Services
    • 2.2.4 Bio-Rad Laboratories Cancer Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Bio-Rad Laboratories Recent Developments/Updates
  • 2.3 Roche Diagnostics
    • 2.3.1 Roche Diagnostics Details
    • 2.3.2 Roche Diagnostics Major Business
    • 2.3.3 Roche Diagnostics Cancer Biomarker Product and Services
    • 2.3.4 Roche Diagnostics Cancer Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Roche Diagnostics Recent Developments/Updates
  • 2.4 Qiagen
    • 2.4.1 Qiagen Details
    • 2.4.2 Qiagen Major Business
    • 2.4.3 Qiagen Cancer Biomarker Product and Services
    • 2.4.4 Qiagen Cancer Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Qiagen Recent Developments/Updates
  • 2.5 Illumina
    • 2.5.1 Illumina Details
    • 2.5.2 Illumina Major Business
    • 2.5.3 Illumina Cancer Biomarker Product and Services
    • 2.5.4 Illumina Cancer Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Illumina Recent Developments/Updates
  • 2.6 GE Healthcare
    • 2.6.1 GE Healthcare Details
    • 2.6.2 GE Healthcare Major Business
    • 2.6.3 GE Healthcare Cancer Biomarker Product and Services
    • 2.6.4 GE Healthcare Cancer Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 GE Healthcare Recent Developments/Updates
  • 2.7 Agilent Technologies
    • 2.7.1 Agilent Technologies Details
    • 2.7.2 Agilent Technologies Major Business
    • 2.7.3 Agilent Technologies Cancer Biomarker Product and Services
    • 2.7.4 Agilent Technologies Cancer Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Agilent Technologies Recent Developments/Updates
  • 2.8 Biomérieux SA
    • 2.8.1 Biomérieux SA Details
    • 2.8.2 Biomérieux SA Major Business
    • 2.8.3 Biomérieux SA Cancer Biomarker Product and Services
    • 2.8.4 Biomérieux SA Cancer Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Biomérieux SA Recent Developments/Updates
  • 2.9 Merck & Co.
    • 2.9.1 Merck & Co. Details
    • 2.9.2 Merck & Co. Major Business
    • 2.9.3 Merck & Co. Cancer Biomarker Product and Services
    • 2.9.4 Merck & Co. Cancer Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Merck & Co. Recent Developments/Updates
  • 2.10 Abbott Laboratories
    • 2.10.1 Abbott Laboratories Details
    • 2.10.2 Abbott Laboratories Major Business
    • 2.10.3 Abbott Laboratories Cancer Biomarker Product and Services
    • 2.10.4 Abbott Laboratories Cancer Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Abbott Laboratories Recent Developments/Updates
  • 2.11 Becton, Dickinson and Company
    • 2.11.1 Becton, Dickinson and Company Details
    • 2.11.2 Becton, Dickinson and Company Major Business
    • 2.11.3 Becton, Dickinson and Company Cancer Biomarker Product and Services
    • 2.11.4 Becton, Dickinson and Company Cancer Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Becton, Dickinson and Company Recent Developments/Updates
  • 2.12 Danaher Corporation
    • 2.12.1 Danaher Corporation Details
    • 2.12.2 Danaher Corporation Major Business
    • 2.12.3 Danaher Corporation Cancer Biomarker Product and Services
    • 2.12.4 Danaher Corporation Cancer Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Danaher Corporation Recent Developments/Updates
  • 2.13 Myriad Genetics
    • 2.13.1 Myriad Genetics Details
    • 2.13.2 Myriad Genetics Major Business
    • 2.13.3 Myriad Genetics Cancer Biomarker Product and Services
    • 2.13.4 Myriad Genetics Cancer Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Myriad Genetics Recent Developments/Updates
  • 2.14 Sysmex Corporation
    • 2.14.1 Sysmex Corporation Details
    • 2.14.2 Sysmex Corporation Major Business
    • 2.14.3 Sysmex Corporation Cancer Biomarker Product and Services
    • 2.14.4 Sysmex Corporation Cancer Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Sysmex Corporation Recent Developments/Updates
  • 2.15 Hologic
    • 2.15.1 Hologic Details
    • 2.15.2 Hologic Major Business
    • 2.15.3 Hologic Cancer Biomarker Product and Services
    • 2.15.4 Hologic Cancer Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Hologic Recent Developments/Updates
  • 2.16 Quest Diagnostics
    • 2.16.1 Quest Diagnostics Details
    • 2.16.2 Quest Diagnostics Major Business
    • 2.16.3 Quest Diagnostics Cancer Biomarker Product and Services
    • 2.16.4 Quest Diagnostics Cancer Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Quest Diagnostics Recent Developments/Updates

3 Competitive Environment: Cancer Biomarker by Manufacturer

  • 3.1 Global Cancer Biomarker Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Cancer Biomarker Revenue by Manufacturer (2019-2024)
  • 3.3 Global Cancer Biomarker Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Cancer Biomarker by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Cancer Biomarker Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Cancer Biomarker Manufacturer Market Share in 2023
  • 3.5 Cancer Biomarker Market: Overall Company Footprint Analysis
    • 3.5.1 Cancer Biomarker Market: Region Footprint
    • 3.5.2 Cancer Biomarker Market: Company Product Type Footprint
    • 3.5.3 Cancer Biomarker Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Cancer Biomarker Market Size by Region
    • 4.1.1 Global Cancer Biomarker Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Cancer Biomarker Consumption Value by Region (2019-2030)
    • 4.1.3 Global Cancer Biomarker Average Price by Region (2019-2030)
  • 4.2 North America Cancer Biomarker Consumption Value (2019-2030)
  • 4.3 Europe Cancer Biomarker Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Cancer Biomarker Consumption Value (2019-2030)
  • 4.5 South America Cancer Biomarker Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Cancer Biomarker Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Cancer Biomarker Sales Quantity by Type (2019-2030)
  • 5.2 Global Cancer Biomarker Consumption Value by Type (2019-2030)
  • 5.3 Global Cancer Biomarker Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Cancer Biomarker Sales Quantity by Application (2019-2030)
  • 6.2 Global Cancer Biomarker Consumption Value by Application (2019-2030)
  • 6.3 Global Cancer Biomarker Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Cancer Biomarker Sales Quantity by Type (2019-2030)
  • 7.2 North America Cancer Biomarker Sales Quantity by Application (2019-2030)
  • 7.3 North America Cancer Biomarker Market Size by Country
    • 7.3.1 North America Cancer Biomarker Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Cancer Biomarker Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Cancer Biomarker Sales Quantity by Type (2019-2030)
  • 8.2 Europe Cancer Biomarker Sales Quantity by Application (2019-2030)
  • 8.3 Europe Cancer Biomarker Market Size by Country
    • 8.3.1 Europe Cancer Biomarker Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Cancer Biomarker Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Cancer Biomarker Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Cancer Biomarker Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Cancer Biomarker Market Size by Region
    • 9.3.1 Asia-Pacific Cancer Biomarker Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Cancer Biomarker Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Cancer Biomarker Sales Quantity by Type (2019-2030)
  • 10.2 South America Cancer Biomarker Sales Quantity by Application (2019-2030)
  • 10.3 South America Cancer Biomarker Market Size by Country
    • 10.3.1 South America Cancer Biomarker Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Cancer Biomarker Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Cancer Biomarker Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Cancer Biomarker Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Cancer Biomarker Market Size by Country
    • 11.3.1 Middle East & Africa Cancer Biomarker Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Cancer Biomarker Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Cancer Biomarker Market Drivers
  • 12.2 Cancer Biomarker Market Restraints
  • 12.3 Cancer Biomarker Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Cancer Biomarker and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Cancer Biomarker
  • 13.3 Cancer Biomarker Production Process
  • 13.4 Cancer Biomarker Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Cancer Biomarker Typical Distributors
  • 14.3 Cancer Biomarker Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Cancer Biomarker. Industry analysis & Market Report on Cancer Biomarker is a syndicated market report, published as Global Cancer Biomarker Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Cancer Biomarker market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,683.08
    4,024.62
    5,366.16
    3,194.64
    4,791.96
    6,389.28
    551,197.20
    826,795.80
    1,102,394.40
    290,719.20
    436,078.80
    581,438.40
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report